| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.93B | $11.31B | $9.87B |
| YoY Revenue Growth % | +5.4% | +14.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.94B | $1.92B | $1.56B |
| Operating Margin % | 16.2% | 16.9% | 15.8% |
| Net Income (GAAP) | $1.54B | $1.53B | $1.23B |
| EBITDA (Normalized) | $2.47B | $2.39B | $1.91B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.11B | $2.11B | $1.78B |
| Capital Expenditures (CapEx) | $666.3M | $593.6M | $444.2M |
| Free Cash Flow (FCF) | $1.45B | $1.51B | $1.34B |
| FCF Margin % | 12.1% | 13.4% | 13.6% |
| Return on Invested Capital (ROIC %) | 29.1% | 28.0% | 9.4% |
| Cash & Short-Term Equivalents | $350.5M | $748.5M | — |
| Total Debt (Short + Long Term) | $2.77B | $2.50B | $5.09B |
| Total Stockholders' Equity | $2.83B | $3.66B | $10.45B |